Microcide Pharmaceuticals (MCDE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Microcide Pharmaceuticals (MCDE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tony Pache who wrote (93)	8/19/1997 1:37:00 AM
From: John Dwyer	of 186

Tony I agree with Rick's assessment - quarterly reports will not move MCDE (and most biotechs in general). However, one item that is on my radar is the increase in the burn at MCDE. They are expanding (new buildings) and adding new staff. I see employment ads in the SF Chronicle frequently. This is all showing up on their balance sheet.They have strong financials so I am not particularly worried but something to keep an eye on. If MCDE is a small part of a balanced portfolio, I would keep it for 2-3 years before evaluating. Only sell it if the story changes. If the story continues to unfold, this one should do well. I like to keep my biotech holdings at around 40% of my portfolio and spread that 40% over 5-10 issues. Some of these are long-term but most are bought and sold based on anticipated news and/or technical factors. All of these companies are extremely high quality so when I make a mistake, I don't mind keeping the stock. The other 60% of my portfolio is in various asset classes, including international stocks, growth stocks, bonds and cash. I also use options for hedging. The point here is that what may be good for me may not be appropriate for you or anyone else. John

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next